The synthetic gastrin-like pentapeptide (ICI 50, 123) may soon replace histamine as the standard stimulant of gastric secretion. As a diagnostic aid and for routine estimations a simple intramuscular test (Johnston and Jepson, 1967) may suffice. For research procedures, however, the rapid metabolism of the stimulant and the ability to produce a plateau of secretion give the intravenous infusion a considerable advantage. Difference of opinion exists as to the dose required to elicit a maximal response by this route (Konturek, 1967; Multicentre Studies, 1967; Wormsley, Mahoney, and Ng, 1966 
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1 ml aliquot from each was titrated against N/100 NaOH, using Topfer's reagent (end point approximately pH 3.5) as indicator. The results were recorded as milliequivalents of 'free' acid per 15-minute period.
Using techniques identical with those described above an entirely different group of four female and 16 male patients were studied to compare the maximal acid secretion obtained with 0.4 ,ug/kg/hr of constant intravenous histamine acid phosphate, and 1-2 tg/kg/hr of similarly administered pentagastrin. All but four of the patients suffered from duodenal ulceration. The histamine test was covered by an intravenous injection of 50 mg mepyramine maleate (Anthisan) administered over a 10-minute period at the start of the histamine infusion, and was performed either on a different day, or at an interval of at least 45 minutes after the end of the pentagastrin infusion.
Ten male volunteers were investigated who had previously undergone vagotomy and drainage for duodenal ulcer. Postoperative insulin testing (Hollander, 1946) had indicated complete vagal gastric denervation in all cases, and at least three months had elapsed since operation. These patients all received increasing doses of pentagastrin at levels of 3 0, 6-0, 12.0 ,ug/kg/hr in a manner similar to that described in the first group of patients. A histamine infusion test was performed 30 minutes after the conclusion of the pentagastrin infusion.
In all cases the peak acid output has been derived by adding the results of the two highest consecutive 15-minute samples and doubling this value to express the result as milliequivalents of free acid per hour. Table I shows that in the seven cases where there was no interval between consecutive doses of pentagastrin the maximum gastric secretory response was achieved by a dose of 0-6 ,ug/kg/hr in one instance and by 1-2 ,ug/kg/hr in a further five. A dose of 6.0 ,g/kg/hr was required for patient K., but the response here was only marginally greater than that obtained by 0.6 ,ug/kg/hr. Of the eight cases in which there was an interval between the doses, four gave maximal values at 0.6 ,g/kg/hr, one at 1.2 ,ug/kg/hr, and the remaining three at 3.0 ,ug/kg/hr. However, it can be seen in many cases that the Patient for patients with intact innervation. At such a dose, side effects were also avoided. In these studies it was not possible to demonstrate the increased acid output which Konturek (1967) claimed occurred with pentagastrin when compared with histamine. His results were calculated from the peak 15-minute sample but study of the coefficients ofvariation ofthe present data suggested the peak 30-minute output was the more reliable basis for derivation of the maximal hourly response. Even so, when the peak 15-minute output is used, the difference in response between pentagastrin and histamine does not approach statistical significance. It was concluded that pentagastrin at a dose of 1.2 ,ug/kg/hr caused a maximal output of gastric acid similar to that produced by a standard histamine infusion test (Lawrie et al, 1964) .
RESULTS
In the group of patients who were examined after a complete surgical vagotomy, the overall findings tended to support the results of the Multicentre . Slight differences in technique were present, however, and some of the patients in the present study were investigated more than 18 months after surgery. The behaviour of the stomach in response to stimulation by pentagastrin under these circumstances may not be identical with that found in the immediate postoperative period. Essentially, there was agreement with the Multicentre Study (1967) that a higher dose of pentagastrin was needed to produce maximal acid secretion after complete gastric vagal denervation, but there was a difference in that a dose level of 6.0 ag/kg/hr appeared adequate.
The importance lies in the fact that had 12.0 gg/kg/hr been necessary, an increased incidence of unpleasant side effects would have been expected. Furthermore the cost, in economic terms, of using commercially available pentagastrin would have become substantially greater.
There was a good correlation between the responses to the optimal doses of pentagastrin and histamine, both in patients with intact and divided vagi. Hence, although it was not possible to present pre-and postoperative secretory data in the same patients, by inference it can be suggested that the reduction in acid secretion, brought about by surgical vagotomy, is likely to be of the same order for both stimulants. This is at variance with the studies of Konturek (1967) , who noted a substantially greater reduction in the pentagastrinstimulated acid than in that stimulated by histamine. In his postvagotomy studies, however, he used a dose of 1.2 gug/kg/hr of pentagastrin which has been shown to give a submaximal stimulus. Konturek (1967) found a reduction of the intravenous histamine response of only 30% which is considerably less than the 60 to 65 % usually observed after complete vagotomy in our experience. Bank, Marks, Louw, and Tigler-Wybrandi (1967) compared the response to subcutaneous pentagastrin at a dose of 6.0 tg/kg and an augmented histamine test in postvagotomy patients, and found an increased response to pentagastrin which was significantly higher. The results of the present study and those of the Multicentre Study (1967) do not support this conclusion, and this may be explained by the fact that subcutaneous and intravenous techniques are not strictly comparable. Williamson, Hume, and Weyers (1967) , who studied the responses to histamine and pentagastrin given subcutaneously, found no significant difference between the mean peak acid outputs either preoperatively or postoperatively.
SUMMARY
The effects of graded doses of pentagastrin, administered by a constant intravenous infusion, have been studied in patients before surgery for duodenal ulceration, and in another similar group of patients several months after complete vagotomy and drainage, to determine the dose required to elicit maximal gastric acid secretion in each instance. In the preoperative patients, a dose of 1.2 gg/kg/hr was found to be adequate but, after a complete surgical vagotomy, it was necessary to increase the dose to 6.0 ,ug/kg/hr to obtain the maximum output. At these le'vels, the responses obtained compared favourably with those obtained from a standard histamine infusion test. 
